EMCDDA. New drugs in Europe, 2014, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 Jul 2015. 879 kB.
Grumann, C; Auwärter, V. Separation of positional isomers of nine 2-phenethylamine-derived designer drugs by liquid chromatography-tandem mass spectrometry Drug Test. Anal., 1 Jul 2018, 10 (7), 1184–1191. 861 kB. https://doi.org/10.1002/dta.2371 #2-MAPB LC,MS
Shevyrin, V; Shafran, Y. Distinguishing of 2-MAPB and 6-MAPB: Solution of the problem J. Mass Spectrom., 1 Oct 2017, 52 (10), 633–637. 474 kB. https://doi.org/10.1002/jms.3970 #2-MAPB MS
Nawyn, J; Kollar, J; Simmon, S; Nguyen, KT; Martin, M. Characterization of isomers of MAPB Forensic Drug Rev., 21 Mar 2016, 70. 3.7 MB. GC,LC,MS,NMR,IR
Sasaki, R; Kato, M; Matsumoto, T; Udagawa, A; Matsuzaki, R. Analytical data of designer drugs of synthetic phenethylamines JCCL, 1 Dec 2015, (55), 43–63. 637 kB. #6 Japanese, English abstract MS,NMR,IR,UV
Islas, ÁA; Moreno, LG; Scior, T. Induced fit, ensemble binding space docking and Monte Carlo simulations of MDMA ‘ecstasy’ and 3D pharmacophore design of MDMA derivatives on the human serotonin transporter (hSERT) Heliyon, 1 Aug 2021, 7 (8), e07784. 3.9 MB. https://doi.org/10.1016/j.heliyon.2021.e07784 #2-MAPB